Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02337166

Regeneration of Human Intrabony Defects With rhFGF-2/HA

Regeneration of Human Intrabony Defects With Recombinant Human Fibroblast Growth Factor 2 in a Hyaluronic Acid Gel Carrier - a Longitudinal, Prospective, Randomized Controlled Clinical Trial

Sponsor: Universidade Federal Fluminense

Conditions Periodontitis

Interventions Periodontal flap surgery a gel containing 4mg/ml rhFGF-2 in sodium hyaluronate

Updated 5 times since 2017 Last updated: Jan 12, 2015 Started: Dec 31, 2002 Primary completion: Aug 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Periodontitis, this trial is completed. The trial is conducted by Universidade Federal Fluminense and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidade Federal Fluminense

Data source: Universidade Federal Fluminense

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.